Consumer Retailing Healthcare Sector

Universal Biosensors

Market Cap: AU$14.3m

Through its subsidiaries, designs and develops electrochemical cells (strips) used in conjunction with point-of-use devices in Australia, the Americas, Europe, and internationally.

ECS Botanics Holdings

Market Cap: AU$14.3m

Engages in the cultivation, manufacture, and sale of medicinal cannabis products in Northwest Victoria.

NeuPath Health

Market Cap: CA$12.6m

Provides chronic pain management services in Canada.

Cambridge Nutritional Sciences

Market Cap: UK£6.8m

Develops, manufactures, and distributes medical diagnostics products for the food sensitivity testing market in the United Kingdom, rest of Europe, North America, South/Central America, India, rest of Asia and the Far East, Africa, and the Middle East.

Aprea Therapeutics

Market Cap: US$9.1m

A clinical-stage biopharmaceutical company, focuses on developing and commercializing novel synthetic lethality-based cancer therapeutics that targets DNA damage response pathways.

Streamline Health Solutions

Market Cap: US$9.0m

Provides health information technology solutions and associated services for hospitals and health systems in North America.

Crigen Resources

Market Cap: AU$13.5m

Operates as a health and wellness company in Australia.

Intelligent Bio Solutions

Market Cap: US$8.9m

A medical technology company, developing rapid, non-invasive testing, and screening solutions.

Scientific Industries

Market Cap: US$8.8m

Engages in the design, manufacture, and marketing of standard benchtop laboratory equipment, weight and measurement, and bioprocessing products in the United States, Germany, and internationally.

Phio Pharmaceuticals

Market Cap: US$8.8m

A a clinical stage biotechnology company, engages in the development of immuno-oncology therapeutics in the United States.

Cloud DX

Market Cap: CA$12.1m

Operates as a remote patient monitoring company in Canada and the United States.

Brainstorm Cell Therapeutics

Market Cap: US$8.8m

A biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases.

Acurx Pharmaceuticals

Market Cap: US$8.8m

A clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections in the United States.

Predictive Oncology

Market Cap: US$8.8m

A knowledge and science-driven company, applies artificial intelligence (AI) to support the discovery and development of cancer therapies.

Xcelerate

Market Cap: US$8.6m

Acquires engineering/patents and applies to early-stage medical technology companies.

IR-Med

Market Cap: US$8.6m

A medical device company, engages in the development of non-invasive devices for various medical indications.

Talphera

Market Cap: US$8.6m

A specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings.

Oxford BioDynamics

Market Cap: UK£6.4m

Operates as a biotechnology company that discovers and develops biomarkers for use in the pharmaceutical and biotechnology industry primarily in the United States and the United Kingdom.

UMC

Market Cap: US$8.6m

Provides medical insurance claims coding and processing, electronic medical records storage, chargemaster review, pricing comparison, and accounts receivable management services to healthcare providers.

BioVaxys Technology

Market Cap: CA$11.7m

A clinical-stage biotechnology company, engages in developing viral and oncology vaccine platforms and immuno-diagnostics.

Biomerica

Market Cap: US$8.5m

A biomedical technology company, engages in developing, patenting, manufacturing, and marketing diagnostic and therapeutic products for the detection and treatment of medical conditions and diseases worldwide.

Surgical Innovations Group

Market Cap: UK£6.3m

Engages in the design, manufacture, and export of medical products for use in laparoscopic and robotic minimally invasive surgery in the United Kingdom, Europe, the Asia Pacific, the United States, and internationally.

Tenon Medical

Market Cap: US$8.3m

A medical device company, engages in the development of implant for the treatment of severe lower back pain in the United States.

BioXcel Therapeutics

Market Cap: US$8.3m

Together with its subsidiary, OnkosXcel Therapeutics LLC, operates as a biopharmaceutical company that utilizes artificial intelligence approaches to develop medicines in neuroscience and immuno-oncology in the United States.

Silexion Therapeutics

Market Cap: US$8.3m

A biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to treat malignant solid tumors.

Resverlogix

Market Cap: CA$11.4m

A late-stage clinical biotechnology company, develops therapeutics for patients with chronic illnesses.

MyHealthChecked

Market Cap: UK£6.1m

Develops, distributes, and commercializes at-home healthcare and wellness tests in the United Kingdom.

Aethlon Medical

Market Cap: US$8.2m

A medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States.

Avecho Biotechnology

Market Cap: AU$12.7m

A biotechnology company, develops and commercializes human and animal health products using its proprietary drug delivery system, tocopherol phosphate mixture (TPM) in Australia, Switzerland, the Americas, and India.

Incanthera

Market Cap: UK£6.1m

A dermatology and oncology therapeutics company, focuses on the dermatological formulation and delivery technologies for various indications.

Feedback

Market Cap: UK£6.0m

A medical imaging technology company, engages in the provision of software and systems to those working in the field of medical imaging.

Althea Group Holdings

Market Cap: AU$12.5m

Manufactures, distributes, and sells cannabis-based medicines and recreational cannabis products in Australia, the United Kingdom, Canada, Germany, and Ireland.

Christina Lake Cannabis

Market Cap: CA$11.2m

Engages in the research and development, cultivation, processing, production, and sale license of cannabis in British Columbia, Canada.

Co-Diagnostics

Market Cap: US$8.1m

Operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally.

Ekso Bionics Holdings

Market Cap: US$8.1m

Designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Europe, the Middle East, Africa, the Asia Pacific, and internationally.

Bio Essence

Market Cap: US$8.1m

Operates as a herbal health, diet, and nutrition company in the United States.